Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

PURPOSE: Despite improvements in treatment, approximately 20% of patients with acute lymphoblastic leukemia (ALL) experience relapse and do poorly. The Therapeutic Advances in Childhood Leukemia (TACL) Consortium was assembled to assess novel drugs for children with resistant leukemia. We hypothesiz...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ko, Richard H., Ji, Lingyun, Barnette, Phillip, Bostrom, Bruce, Hutchinson, Raymond, Raetz, Elizabeth, Seibel, Nita L., Twist, Clare J., Eckroth, Elena, Sposto, Richard, Gaynon, Paul S., Loh, Mignon L.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2010
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815999/
https://ncbi.nlm.nih.gov/pubmed/19841326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.2950
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker